These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6103460)

  • 21. Dissociation between changes in immunoreactive parathormone and its biological indices induced by cimetidine in primary hyperparathyroidism.
    van der Velden PC; Fischer HR; Hackeng WH; Schopman W; Koorevaar G; den Ottolander GJ; Silberbusch J
    Acta Med Scand; 1981; 210(6):467-70. PubMed ID: 6277160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cimetidine treatment of primary hyperparathyroidism].
    Caron P; Gaillard J; Barousse C; Bouissou H; Louvet JP; Boulard C
    Ann Med Interne (Paris); 1984; 135(1):12-5. PubMed ID: 6322636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cimetidine and hyperparathyroidism.
    Pettengell KE; Grayson MJ
    Lancet; 1980 May; 1(8178):1134. PubMed ID: 6103462
    [No Abstract]   [Full Text] [Related]  

  • 24. Cimetidine in secondary hyperparathyroidism.
    Kovarik J; Graf H; Woloszczuk W; Stummvoll HK
    Ann Intern Med; 1982 Mar; 96(3):379. PubMed ID: 7059107
    [No Abstract]   [Full Text] [Related]  

  • 25. Cimetidine treatment of azotemic secondary hyperparathyroidism.
    Robinson MF; Johnson WJ; Heath H
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1206-9. PubMed ID: 6281294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of H2-receptor antagonists to affect serum calcium and immunoreactive parathyroid hormone levels in normal subjects and patients with primary hyperparathyroidism.
    Pols HA; De Jong MJ; Juttmann JR; Lockefeer JH
    Neth J Med; 1983; 26(6):149-52. PubMed ID: 6310424
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of long-term cimetidine treatment on left ventricular function in haemodialysis patients with active hyperparathyroidism.
    Lai KN; Fassett RG; Mathew TH
    Br J Clin Pharmacol; 1982 May; 13(5):693-7. PubMed ID: 7082538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of cimetidine on parathyroid function and histopathology in primary hyperparathyroidism.
    Sotsiou FC; Singhellakis PN; Nikou AD; Pappas AD; Vambouka C; Sklivagou NG; Ikkos DG
    J Pathol; 1987 Apr; 151(4):271-8. PubMed ID: 3585586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cimetidine and circulating calciotropic hormone levels in uremic patients: evidence for a suppressive effect on calcitonin secretion.
    Sebert JL; Decourcelles PH; Morinière P; Calmette C; Gueris J; Makdassi R; Khassouf J; Andrejak M; Fournier A
    Miner Electrolyte Metab; 1982 Dec; 8(6):293-9. PubMed ID: 7167135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does cimetidine inhibit parathyroid hormone secretion?
    Sherwood J; Reinhard D; Garcia M
    N Engl J Med; 1979 Jan; 300(4):200-1. PubMed ID: 759855
    [No Abstract]   [Full Text] [Related]  

  • 31. Blockers of beta and H2 receptors and secondary hyperparathyroidism in uraemia.
    Makdassi R; Decourcelle PH; Moriniere P; Coevoet B; de Fremont JF; Kassouf J; Roussel A; Gheerbrand JD; Andrejak M; Fournier A
    Proc Eur Dial Transplant Assoc; 1981; 18():642-7. PubMed ID: 7329992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cimetidine in the therapy of secondary hyperparathyroidism in uremia with hemodialytic treatment].
    Antonucci F; Gropuzzo M; Messa P; Montanaro D; Adorati M; Paviotti G; Favazza A; Susanna F; Zilli M; Messa M
    Minerva Nefrol; 1983; 30(3):133-9. PubMed ID: 6646487
    [No Abstract]   [Full Text] [Related]  

  • 33. Reduction by cimetidine of serum parathyroid hormone levels in uremic patients.
    Jacob AI; Lanier D; Canterbury J; Bourgoignie JJ
    N Engl J Med; 1980 Mar; 302(12):671-4. PubMed ID: 7354765
    [No Abstract]   [Full Text] [Related]  

  • 34. [Acute hypercalcemic crisis in primary hyperparathyroidism].
    Kistler HJ
    Minerva Med; 1974 Dec; 65(91):4815-20. PubMed ID: 4449611
    [No Abstract]   [Full Text] [Related]  

  • 35. [The efficacy and safety of intravenous bisphosphonates in the treatment of primary hyperparathyroidism complicated by hypercalcemia crisis].
    Han GY; Wang O; Xing XP; Meng XW; Lian XL; Guan H; Ye W; Xia WB; Li M; Jiang Y; Hu YY; Liu HC; Cui QC
    Zhonghua Nei Ke Za Zhi; 2009 Sep; 48(9):729-33. PubMed ID: 20079207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cimetidine-induced PTH variations in uraemic patients evaluated with the aid of antisera against the terminal carboxyl and amino groups of the hormone molecule.
    Fiore CE; Malatino LS; Tamburino C; Lunetta M; Heynen G
    Horm Metab Res; 1981 Nov; 13(11):642-5. PubMed ID: 7308973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Attempted treatment of primary hyperparathyroidism with cimetidine].
    Caron P; Louvet JP
    Presse Med; 1984 Oct; 13(38):2326. PubMed ID: 6095248
    [No Abstract]   [Full Text] [Related]  

  • 38. Coumarin and cimetidine in malignant melanoma.
    Thornes RD; Lynch G; Sheehan MV
    Ir Med J; 1983 Jan; 76(1):53. PubMed ID: 6826342
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of cimetidine in hemorrhages of the upper gastrointestinal tract].
    Procacciante F; Citone G; Montesani C; Giannoni F; Ribotta G
    Clin Ter; 1979 Sep; 90(5):445-60. PubMed ID: 317810
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of intravenous and oral cimetidine in primary hyperparathyroidism.
    Wiske PS; Epstein S; Norton JA; Bell NH; Johnston CC
    Horm Metab Res; 1983 May; 15(5):245-8. PubMed ID: 6873872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.